NitroMed, JHP Pharmaceuticals LLC deal

JHP will acquire NitroMed's BiDil business for $24.5 million in cash, plus up to $1.8 million for inventory. The fixed-dose combination of hydralazine hydrochloride and disosorbide dinitrate is marke...